MaxCyte Inc - Maryland, US-based cell-engineering focused company - Forms new scientific advisory board that will reflect on research in molecular design and cell engineering and gain an understanding of translational development, in order to leverage the benefits of impactful discoveries for therapeutic applications. Board will include scientists, Oliver Rando, Marcela Maus, Avery Posey and Nako Nakatsuka.
Doug Doerfler President and CEO says: "These four dynamic scientists are deeply connected in the scientific community through their work and memberships in professional societies and will bring the innovation and support needed to nurture our early-stage projects from beginning to end."
Current stock price: 392.00 pence, closed up 6.0% on Wednesday
12-month change: down 8.9%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved
MaxCyte (MXCT)